MAPUTO-PCO-FY23-02: Leadership Training for Adolescent Girls and Young Women
Closed
This grant is closed. A newer notice from the same program is open now: Advancing Global Health (DFOP0017890). Status: Closes February 14, 2027 (99 days left). It is in our archive of U.S. Mission to Mozambique notices from 2023.
U.S. Mission to Mozambique offered grants of up to $40,000 (at least $40,000) to nonprofits and businesses. It expected to make one award worth $1 in total. Applications closed on August 4, 2023.
From the official notice on Grants.gov, last changed June 23, 2023. Checked November 7, 2026.
- Award ceiling$40,000
- Award floor$40,000
- Total funding$1
- Expected awards1
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 23, 2023 |
|---|---|
| Deadline | August 4, 2023 |
| Archived by Grants.gov | September 3, 2023 |
Who can apply
This opportunity was open to nonprofits and businesses.
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
Organizations must be able to demonstrate strong training skills and results in mentorship and women empowerment
Is this a realistic fit?
- Past The U.S. President's Emergency Plan for AIDS Relief Programs awards averaged $146,897; this notice allows up to $40,000 per award.
- Most of the program's money (74% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
PEPFAR announced the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe) Partnership on World AIDS Day 2014. In 2015, DREAMS was planned with full grassroots participation. In 2016, DREAMS implementation began in ten countries of Sub-Saharan African countries including Mozambique. DREAMS focuses on HIV prevention interventions for Adolescent Girls and Young Women (AGYW) from 10 to 24 year olds. The program provides a comprehensive package of core interventions to address many of the factors that make girls and young women particularly vulnerable to HIV, including gender-based violence, exclusion from economic opportunities, and a lack of access to secondary school and broad components, such as parenting/caregiver programs and the specific evidence-based curricula for HIV and Violence prevention. The goal of DREAMS is to deliver on bold U.S. targets by supporting a multi-sectoral core package of interventions that goes beyond the health sector, addressing the structural drivers that directly and indirectly increase girls’ HIV risk, including poverty, gender inequality, sexual violence, and lack of education. The DREAMS Ambassador program was initiated in 2016 as way to recognize that adolescent girls and young women (AGYW) have limited access to adolescent friendly services that respond to their sexual reproductive health needs. The participation and leadership of AGYW is essential in the decision-making processes implementation of interventions and in the that affect their lives to achieve better health for AGYW. The focus of this program is to select and train AGYW to advocate for the rights of youth, provide leadership for DREAMS interventions, and to link their peers to the services available (in the community, schools, and the health centers), in order to maximize the impact of the DREAMS program. Among of the responsibilities of the DREAMS Ambassadors, their mission is to generate public attention for the DREAMS program and the problems that affect adolescent girls and youth in their communities and being and be the public face in existing structures such as girls’ clubs and safe spaces in the community. Mozambique still has one of the highest numbers of early pregnancy and female school drop-out it also ranks very high in lack of opportunities for young women to actively raise their voices in the society.
Who has won The U.S. President's Emergency Plan for AIDS Relief Programs grants before
From fiscal 2021 to 2025, The U.S. President's Emergency Plan for AIDS Relief Programs (19.029) awarded $117 million across 794 grant awards, an average of $146,897 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Maryland | 1 | $89.9 million |
| Miscellaneous Foreign Awardees | 321 | $7.9 million | |
| Ho Chi Minh City HIV/AIDS Association | 4 | $673,404 | |
| Tamra for Social Development Organization (TDS) | 3 | $638,998 | |
| National Empowerment Network of People Living with HIV / AIDS (Nephak) | 3 | $513,403 |
Applying now
This notice no longer takes applications. Apply under the newer notice, DFOP0017890, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is MAPUTO-PCO-FY23-02 still open?
No. It closed on August 4, 2023. A newer notice is open: DFOP0017890, closes February 14, 2027 (99 days left).
Who can apply for Leadership Training for Adolescent Girls and Young Women?
U.S. Mission to Mozambique accepted applications from nonprofits and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Leadership Training for Adolescent Girls and Young Women?
Closed August 4, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $40,000 each. About $1 in total for one award.
Who has won The U.S. President's Emergency Plan for AIDS Relief Programs grants before?
The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Miscellaneous Foreign Awardees, Ho Chi Minh City HIV/AIDS Association. The program made 794 awards worth $117 million in that time.
Similar open grants
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)